Daseke, Inc. (DSKE) Tops Q4 EPS by 19c

Daseke, Inc. (NASDAQ: DSKE) reported Q4 EPS of $0.25, $0.19 better than the analyst estimate of $0.06. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $398.03 million.

For earnings history and earnings-related data on Daseke, Inc. (DSKE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c